Skip to main content
Clinical Trials/IRCT20160914029818N3
IRCT20160914029818N3CompletedPhase 3

Clinical trial Study of the effect of Myrtoid and 2% diltiazem with placebo in treatment of complications of chronic anal fissure patients

Bagheiat-allah University of Medical Sciences0 sites99 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
99

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 65 years (—)
Sex
All

Inclusion Criteria

  • Having at least 2 months of chronic anal fissure

Exclusion Criteria

  • Patients with Crohn's disease
  • Patients with colon cancer
  • Patients with diabetes
  • History of anal surgery

Investigators

Sponsor
Bagheiat-allah University of Medical Sciences

Similar Trials